A detailed history of Smith Chas P & Associates Pa Cpas transactions in Becton Dickinson & CO stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 1,787 shares of BDX stock, worth $435,045. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,787
Previous 1,815 1.54%
Holding current value
$435,045
Previous $437,000 7.32%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

SELL
$220.02 - $243.75 $6,160 - $6,825
-28 Reduced 1.54%
1,787 $405,000
Q3 2024

Oct 11, 2024

SELL
$221.47 - $242.41 $442 - $484
-2 Reduced 0.11%
1,815 $437,000
Q1 2024

Apr 25, 2024

BUY
$233.45 - $247.73 $424,178 - $450,125
1,817 New
1,817 $449,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $69.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Smith Chas P & Associates Pa Cpas Portfolio

Follow Smith Chas P & Associates Pa Cpas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Chas P & Associates Pa Cpas, based on Form 13F filings with the SEC.

News

Stay updated on Smith Chas P & Associates Pa Cpas with notifications on news.